These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 2425330)

  • 1. The glycoconjugate derived from a Leishmania major receptor for macrophages is a suppressogenic, disease-promoting antigen in murine cutaneous leishmaniasis.
    Mitchell GF; Handman E
    Parasite Immunol; 1986 May; 8(3):255-63. PubMed ID: 2425330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Murine cutaneous leishmaniasis: resistance in reconstituted nude mice and several F1 hybrids infected with Leishmania tropica major.
    Mitchell GF
    J Immunogenet; 1983 Oct; 10(5):395-412. PubMed ID: 6606002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. L3T4+ T cells promoting susceptibility to murine cutaneous leishmaniasis express the surface marker Ly-24 (Pgp-1).
    Moll H; Scollay R
    Eur J Immunol; 1989 Feb; 19(2):307-14. PubMed ID: 2467816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterologous protection in murine cutaneous leishmaniasis.
    Mitchell GF; Handman E
    Immunol Cell Biol; 1987 Oct; 65 Pt 5():387-92. PubMed ID: 3436638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunization with Leishmania receptor for macrophages protects mice against cutaneous leishmaniasis.
    Handman E; Mitchell GF
    Proc Natl Acad Sci U S A; 1985 Sep; 82(17):5910-4. PubMed ID: 3862105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Murine cutaneous leishmaniasis: resistance correlates with the capacity to generate interferon-gamma in response to Leishmania antigens in vitro.
    Sadick MD; Locksley RM; Tubbs C; Raff HV
    J Immunol; 1986 Jan; 136(2):655-61. PubMed ID: 3079789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Murine cutaneous leishmaniasis: disease patterns in intact and nude mice of various genotypes and examination of some differences between normal and infected macrophages.
    Handman E; Ceredig R; Mitchell GF
    Aust J Exp Biol Med Sci; 1979 Feb; 57(1):9-29. PubMed ID: 314286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccination against cutaneous leishmaniasis in a murine model. I. Induction of protective immunity with a soluble extract of promastigotes.
    Scott P; Pearce E; Natovitz P; Sher A
    J Immunol; 1987 Jul; 139(1):221-7. PubMed ID: 3495599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccination against cutaneous leishmaniasis in a murine model. II. Immunologic properties of protective and nonprotective subfractions of soluble promastigote extract.
    Scott P; Pearce E; Natovitz P; Sher A
    J Immunol; 1987 Nov; 139(9):3118-25. PubMed ID: 3499465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Susceptibility to murine cutaneous leishmaniasis correlates with the capacity to generate interleukin 3 in response to leishmania antigen in vitro.
    Lelchuk R; Graveley R; Liew FY
    Cell Immunol; 1988 Jan; 111(1):66-76. PubMed ID: 3257416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leishmania tropica major in mice: vaccination against cutaneous leishmaniasis in mice of high genetic susceptibility.
    Mitchell GF; Handman E
    Aust J Exp Biol Med Sci; 1983 Feb; 61(Pt 1):11-25. PubMed ID: 6870673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunization of susceptible hosts with a soluble antigen fraction from Leishmania major leads to aggravation of murine leishmaniasis mediated by CD4+ T cells.
    Bogdan C; Schröppel K; Lohoff M; Röllinghoff M; Solbach W
    Eur J Immunol; 1990 Dec; 20(12):2533-40. PubMed ID: 1980108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppressive effect of cyclosporin A on the development of Leishmania tropica-induced lesions in genetically susceptible BALB/c mice.
    Solbach W; Forberg K; Kammerer E; Bogdan C; Röllinghoff M
    J Immunol; 1986 Jul; 137(2):702-7. PubMed ID: 3487578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leishmania antigens presented by GM-CSF-derived macrophages protect susceptible mice against challenge with Leishmania major.
    Doherty TM; Coffman RL
    J Immunol; 1993 Jun; 150(12):5476-83. PubMed ID: 8515072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunoregulatory pathways in murine leishmaniasis: different regulatory control during Leishmania mexicana mexicana and Leishmania major infections.
    Alexander J; Kaye PM
    Clin Exp Immunol; 1985 Sep; 61(3):674-82. PubMed ID: 3907906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergy between activated Leishmania major-specific CD4+ T lymphocytes and bone-marrow-derived cells in the exacerbation of murine cutaneous leishmaniasis.
    Mendonça SC; Titus RG; Louis JA
    Res Immunol; 1990; 141(9):865-78. PubMed ID: 1983098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of vaccinal effectiveness of preparations containing membrane antigens of Leishmania (L.) amazonensis in experimental cutaneous leishmaniasis model.
    Ribeiro JG; Ferreira AS; Macedo SRA; Rossi NRDLP; da Silva MCP; Guerra RNM; de Barros NB; Nicolete R
    Int Immunopharmacol; 2017 Jun; 47():227-230. PubMed ID: 28433944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of variables associated with promotion of resistance and its abrogation in T cell-reconstituted nude mice infected with Leishmania major.
    Moll H; Mitchell GF
    J Parasitol; 1988 Dec; 74(6):993-8. PubMed ID: 3264023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The correlation between delayed hypersensitivity, lymphocyte activation and protective immunity in experimental murine leishmaniasis.
    De Rossell RA; Bray RS; Alexander J
    Parasite Immunol; 1987 Jan; 9(1):105-15. PubMed ID: 3562057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sex-influenced response in the pathogenesis of cutaneous leishmaniasis in mice.
    Giannini MS
    Parasite Immunol; 1986 Jan; 8(1):31-7. PubMed ID: 3960590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.